On the business value of clinical imaging and face-to-face communication.
Aside from his role with GlaxoSmithKline (GSK), Paul M. Matthews, M.D., is professor of clinical neurosciences at Imperial College, London, and (honorary) MRC clinical research professor at the University of Oxford.
In this candid and instructive interview, Paul talks with Victoria Newing about:
How clinical imaging can transform drug development
A clear communication strategy for R&D
How GSK is transforming its organizational structure
What is required to act on data created by cutting edge technology
Link to this comment:
All Comments (0)